T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma
N Engl J Med
.
2022 Aug 11;387(6):558-561.
doi: 10.1056/NEJMe2209692.
Authors
Sham Mailankody
1
,
Ola Landgren
1
Affiliation
1
From the Myeloma and Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (S.M.); and the Division of Myeloma, Sylvester Comprehensive Cancer Center, University of Miami, Miami (O.L.).
PMID:
35947712
DOI:
10.1056/NEJMe2209692
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Immunotherapy* / methods
Immunotherapy* / trends
Immunotherapy, Adoptive
Multiple Myeloma* / drug therapy
Multiple Myeloma* / immunology
Multiple Myeloma* / therapy
T-Lymphocytes* / immunology